(Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | (Q6)Jun 30, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.18%9.97B | 63.80%20.4B | 36.22%9.13B | 44.75%12.45B | 345.86%6.7B | 27.71%8.6B | -13.52%1.5B | 0.03%6.74B | -42.24%1.74B | 27.78%6.73B |
Operating income | 9.18%9.97B | 63.80%20.4B | 36.22%9.13B | 44.75%12.45B | 345.86%6.7B | 27.71%8.6B | -13.52%1.5B | 0.03%6.74B | -42.24%1.74B | 27.78%6.73B |
Cost of sales | -28.54%-8.83B | -62.18%-15.63B | -29.50%-6.87B | -70.66%-9.64B | -505.88%-5.3B | -29.90%-5.65B | 18.45%-875.1M | 14.03%-4.35B | 55.55%-1.07B | -20.86%-5.06B |
Operating expenses | -28.54%-8.83B | -62.18%-15.63B | -29.50%-6.87B | -70.66%-9.64B | -505.88%-5.3B | -29.90%-5.65B | 18.45%-875.1M | 14.03%-4.35B | 55.55%-1.07B | -20.86%-5.06B |
Gross profit | -49.49%1.14B | 69.33%4.76B | 61.65%2.26B | -4.79%2.81B | 122.98%1.4B | 23.72%2.95B | -5.57%628.29M | 42.43%2.39B | 11.65%665.36M | 54.46%1.68B |
Selling expenses | 30.57%-367.53M | -43.93%-1.07B | -113.98%-529.34M | -65.58%-743.04M | -42.46%-247.38M | -144.54%-448.74M | -177.03%-173.65M | 6.13%-183.5M | 29.55%-62.68M | -33.33%-195.48M |
Administrative expenses | 2.03%-452.33M | -19.60%-978.04M | -30.38%-461.7M | -58.27%-817.77M | -43.40%-354.11M | -21.80%-516.7M | -44.68%-246.94M | -81.72%-424.22M | -88.71%-170.68M | -41.68%-233.45M |
Revaluation surplus | -103.78%-7.96M | 9,527.97%250.91M | 12,774.37%210.5M | -97.93%2.61M | -98.52%1.64M | 49.88%126.16M | 146.04%110.11M | -76.56%84.17M | -86.31%44.75M | --359.04M |
-Changes in the fair value of investment property | -103.78%-7.96M | 9,527.97%250.91M | 12,774.37%210.5M | -97.93%2.61M | -98.52%1.64M | 49.88%126.16M | 146.04%110.11M | -76.56%84.17M | -86.31%44.75M | --359.04M |
Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---49.54M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---49.54M |
Special items of operating profit | -122.48%-109.54M | -4.73%685.35M | 65.88%487.23M | 61.58%719.36M | 18.62%293.72M | 79.17%445.19M | -20.33%247.62M | 1,672.29%248.47M | 61,445.94%310.81M | -109.23%-15.8M |
Operating profit | -89.53%206.42M | 85.00%3.65B | 80.06%1.97B | -22.90%1.97B | 93.63%1.09B | 21.18%2.56B | -28.21%565.42M | 37.08%2.11B | 10.04%787.55M | 63.06%1.54B |
Financing income | 310.24%217.93M | 57.85%236.53M | -14.65%53.12M | 22.34%149.85M | -2.62%62.24M | 28.90%122.49M | 43.16%63.91M | 112.45%95.03M | 76.43%44.64M | 192.31%44.73M |
Financing cost | 5.83%-9.31M | 17.90%-19.48M | 20.87%-9.89M | -18.74%-23.73M | -37.53%-12.5M | 72.12%-19.98M | 78.62%-9.09M | -1.01%-71.66M | -1,073.17%-42.5M | -1,014.79%-70.95M |
Special items of earning before tax | 49.34%-13.84M | -144.58%-11.76M | -67.26%-27.33M | 222.44%26.38M | 37.13%-16.34M | -127.81%-21.55M | -130.44%-25.99M | -6.52%77.47M | 8,007.50%85.37M | 1,153.33%82.87M |
Earning before tax | -79.81%401.19M | 81.39%3.86B | 76.14%1.99B | -19.49%2.13B | 89.86%1.13B | 19.31%2.64B | -32.09%594.25M | 38.53%2.21B | 18.51%875.06M | 66.31%1.6B |
Tax | 68.01%-215.85M | -96.40%-1.34B | -72.37%-674.81M | 37.25%-683.5M | -79.77%-391.49M | -18.79%-1.09B | 10.70%-217.77M | -50.90%-917.04M | 33.30%-243.87M | -49.69%-607.74M |
After-tax profit from continuing operations | -85.88%185.34M | 74.28%2.51B | 78.15%1.31B | -7.02%1.44B | 95.69%736.74M | 19.69%1.55B | -40.35%376.48M | 30.93%1.3B | 69.32%631.2M | 78.48%990.13M |
Earning after tax | -85.88%185.34M | 74.28%2.51B | 78.15%1.31B | -7.02%1.44B | 95.69%736.74M | 19.69%1.55B | -40.35%376.48M | 30.93%1.3B | 69.32%631.2M | 78.48%990.13M |
Minority profit | -76.64%181.97M | 1,010.39%1.63B | 167.09%778.94M | -71.58%146.85M | 214.17%291.64M | 69.04%516.73M | -53.55%92.83M | 139.01%305.68M | 294.58%199.83M | 22.97%127.9M |
Profit attributable to shareholders | -99.37%3.37M | -31.79%883.96M | 19.87%533.52M | 25.22%1.3B | 56.91%445.09M | 4.46%1.03B | -34.24%283.65M | 14.90%990.75M | 33.90%431.37M | 91.29%862.24M |
Basic earnings per share | -99.40%0.0009 | -31.79%0.2489 | 19.87%0.1502 | 25.22%0.3649 | 56.82%0.1253 | 4.44%0.2914 | -34.24%0.0799 | 14.91%0.279 | 33.96%0.1215 | 91.33%0.2428 |
Diluted earnings per share | -99.40%0.0009 | -31.79%0.2489 | 19.87%0.1502 | 25.22%0.3649 | 56.82%0.1253 | 4.44%0.2914 | -34.24%0.0799 | 14.91%0.279 | 33.96%0.1215 | 91.33%0.2428 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data